Cascone, Tina

Author Profile

Claim This Author Profile

Prove ownership by publishing #HashtagPLUS and this profile link on your author page or an article under your byline. A moderator or admin will review the request before it merges into your real HashtagPLUS username.

0 karma0 postsjoined 4 days ago

ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2

🌐 nature.comSource

Patients with resectable non-small cell lung cancer (NSCLC) remain at high risk of relapse despite perioperative treatment1-3. NeoCOAST-2 (NCT05061550), a phase 2, randomised platform trial, tested novel perioperative treatments in patients with stage IIA–IIIB NSCLC. At primary a

#lm #oncology #orcid #university #access #ctdna #article #englishlanguage

4 days ago

Menu

Cascone, Tina